Skip to main content
Clinical Trials/NCT06516939
NCT06516939RecruitingNot Applicable

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Shanghai Dermatology Hospital1 site in 1 country28 target enrollmentStarted: June 10, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
28
Locations
1
Primary Endpoint
erythema index

Study Overview

Brief Summary

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3
  • No related skin care products including bovine alkaline fibroblast growth factor were used within 1 month before participating in the experiment, and photoelectric treatment measures were not carried out
  • Physical sunscreen should be strict during enrollment

Exclusion Criteria

  • Have serious heart, liver, kidney, and blood system diseases, and severe immunocompromise
  • Patients with mental illness or cancer
  • Those who have received glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics or tretinoin within 3 months
  • Those who are allergic to basic fibroblast growth factor gel and its components
  • Acute dermatitis of the face and perifolliculitis

Arms & Interventions

Bovine Basic Gel

Placebo Comparator

Intervention: Bovine Basic Gel (Drug)

The Application of Bovine Basic Fibroblast Growth Factor Gel

Experimental

Intervention: bFGF (Drug)

Outcomes

Primary Outcomes

erythema index

Time Frame: 0、1、2、4 week

The change rate in lesion clearance of face at 1 month after treatment will be measured as the primary outcome

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Shanghai Dermatology Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

The Application of Bovine Basic Fibroblast... | Clinical Trial